Literature DB >> 12981828

[Triethylenmelamine, a new drug in therapy of leukemia; results in 29 cases].

L HEILMEYER, I HEILMEYER.   

Abstract

Entities:  

Keywords:  LEUKEMIA/therapy

Mesh：

Year:  1952        PMID： 12981828     DOI： 10.1007/BF01472179

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN： 0023-2173


× No keyword cloud information.
  3 in total

1.  Triethylene melamine in the treatment of Hodgkin's disease and allied neoplasms.

Authors:  C P RHOADS; D A KARNOFSKY; J H BURCHENAL; L F CRAVER
Journal:  Trans Assoc Am Physicians       Date:  1950

2.  RETARDATION of tumor growth in mice by oral administration of ethylenimine derivatives.

Authors: 
Journal:  Arch Biochem       Date:  1950-04

3.  New cytotoxic agents with tumour-inhibitory activity.

Authors:  F L ROSE; J A HENDRY; A L WALPOLE
Journal:  Nature       Date:  1950-06-24       Impact factor: 49.962
  3 in total
  2 in total

1.  [Present status of chemotherapy in human neoplastic diseases].

Authors:  J PIRWITZ
Journal:  Klin Wochenschr       Date:  1957-05-01

2.  [Fatal uremia after triethylenemelamine treatment in chronic lymphatic leukemia].

Authors:  H MARTIN
Journal:  Klin Wochenschr       Date:  1953-03-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.